310 related articles for article (PubMed ID: 28506251)
1. Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus.
Subramanya SH; Sharan NK; Baral BP; Hamal D; Nayak N; Prakash PY; Sathian B; Bairy I; Gokhale S
BMC Microbiol; 2017 May; 17(1):113. PubMed ID: 28506251
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Yeasts from Scarlet ibises (Eudocimus ruber): A focus on monitoring the antifungal susceptibility of Candida famata and closely related species.
Brilhante RSN; Silva ALD; Monteiro FOB; Guedes GMM; Sales JA; Oliveira JS; Maia Junior JE; Miranda SA; Sidrim JJC; Alencar LP; Castelo-Branco DSCM; Cordeiro RA; Pereira Neto WA; Rocha MFG
Med Mycol; 2017 Oct; 55(7):725-732. PubMed ID: 28204651
[TBL] [Abstract][Full Text] [Related]
4. Diversity, Virulence Factors, and Antifungal Susceptibility Patterns of Pathogenic and Opportunistic Yeast Species in Rock Pigeon (
Abulreesh HH; Organji SR; Elbanna K; Osman GEH; Almalki MHK; Abdel-Malek AY; Ghyathuddin AAK; Ahmad I
Pol J Microbiol; 2019 Dec; 68(4):493-504. PubMed ID: 31880893
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
6. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
7. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Chen TC; Chen YH; Chen YC; Lu PL
Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.
Liao Y; Yang S; Cong L; Lu X; Ao J; Yang R
Antimicrob Agents Chemother; 2014 Dec; 58(12):7615-6. PubMed ID: 25246408
[No Abstract] [Full Text] [Related]
11. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
12. In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.
Montoya AM; Luna-Rodríguez CE; Gracia-Robles G; Rojas OC; González GM
Arch Microbiol; 2019 Oct; 201(8):1147-1149. PubMed ID: 31147748
[TBL] [Abstract][Full Text] [Related]
13. Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples.
Danis Vijay D; Jayanthi S; Meenakshi N; Meharaj SHS; Sujhithra A; Perumal J
Microb Pathog; 2019 Dec; 137():103750. PubMed ID: 31536801
[TBL] [Abstract][Full Text] [Related]
14. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
15. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Carrillo-Muñoz AJ; Quindós G; del Valle O; Santos P; Giusiano G; Ezkurra PA; Estivill MD; Casals JB
Chemotherapy; 2008; 54(1):38-42. PubMed ID: 18073469
[TBL] [Abstract][Full Text] [Related]
16. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
17. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
Kawai A; Yamagishi Y; Mikamo H
J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
[TBL] [Abstract][Full Text] [Related]
19. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
20. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
Córdoba S; Vivot W; Bosco-Borgeat ME; Taverna C; Szusz W; Murisengo O; Isla G; Davel G;
Rev Argent Microbiol; 2011; 43(3):176-85. PubMed ID: 22430989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
